Rajan Sharma
Stock Analyst at Goldman Sachs
(0.07)
# 4,594
Out of 5,241 analysts
5
Total ratings
25%
Success rate
-42.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $19.65 | -63.10% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $181.58 | -46.58% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $49.67 | -5.38% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $28.05 | +181.64% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $19.65
Upside: -63.10%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $181.58
Upside: -46.58%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $49.67
Upside: -5.38%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $28.05
Upside: +181.64%